Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Pharmability AB
AB
Active
Org 5591490213
Alviksvägen 1, 167 53
Bromma
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2018 · 8 years old
1 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pharmability AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (3)
CR
Carl-Wilhelm Robin Ericsson
Audit
Audit
2024
LM
Leo Magnus Holmgren
Chief Executive Officer
Chief Executive Officer
2021
PC
Pia Caroline Ståhle
Auditor Substitute
Auditor Substitute
2024
Former (1)
LJ
Leif Johan Christer Lüsch
Audit
Audit
2021 – 2024
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (7)
EM
Ellen Mona Gratia Wilcke
Board of Directors
Board of Directors
2021
PV
Pirkko Vilja Päivikki Tamsen
Board of Directors
Board of Directors
2021
PS
Peder Sven Walberg
Board of Directors
Board of Directors
2025
AM
Anna-Lena Marie Spetz
Board of Directors
Board of Directors
2022
JE
John Erik Andersson Moll
Board of Directors
Board of Directors
2022
JN
Jan-Erik Nyström
Chairman
Chairman
2021
CC
Carl Christian Krog-Jensen
Board of Directors
Board of Directors
2025
Former (4)
LM
Ludwig Magnus Holmgren
Deputy Board Member
Deputy Board Member
2021 – 2021
ME
Maria Elisabet Tell
Board of Directors
Board of Directors
2021 – 2022
GE
Gustav Evert Notander
Board of Directors
Board of Directors
2024 – 2025
SE
Stina Elna Josefin Wallmark
Board of Directors
Board of Directors
2021 – 2024
Aktionærer
Pr. seneste årsrapport
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Pharmability AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network